SGRY (Surgery Partners) ROE % Adjusted to Book Value: -9.17% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGRY Surgery Partners Inc SGRY
66 GF Score
Price $14.92
GF Value $26.81
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Surgery Partners ROE % Adjusted to Book Value?

Surgery Partners SGRY -2.61% 66 ROE % Adjusted to Book Value is -9.17% as of Mar. 2026. GuruFocus rates SGRY with a GF Score™ of 66/100 and a GF Value™ of $26.81 (Possible Value Trap). The stock has 4 warning signs investors should review.

Surgery Partners's ROE % for the quarter that ended in Mar. 2026 was -8.44%. Surgery Partners's PB Ratio for the quarter that ended in Mar. 2026 was 0.92. Surgery Partners's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -9.17%.


Surgery Partners ROE % Adjusted to Book Value Related Terms


Surgery Partners ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Surgery Partners's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgery Partners ROE % Adjusted to Book Value Chart

Surgery Partners Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.97 -2.01 -0.29 -5.93 -3.80

Surgery Partners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.88 -0.35 -3.24 -2.98 -9.17

SGRY vs AVAH, ASTH, ADUS: ROE % Adjusted to Book Value Comparison

For the Medical Care Facilities subindustry, Surgery Partners's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgery Partners ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Surgery Partners's ROE % Adjusted to Book Value falls into.


SGRY
66GF Score
Surgery Partners Inc SGRY
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Surgery Partners ROE % Adjusted to Book Value Calculation

Surgery Partners's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4.45% / 1.17
=-3.80%

Surgery Partners's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-8.44% / 0.92
=-9.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -9.17% mean?
Surgery Partners (SGRY) has a ROE % Adjusted to Book Value of -9.17% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Surgery Partners and its competitors.
Is Surgery Partners' ROE % Adjusted to Book Value too high?
Surgery Partners' current ROE % Adjusted to Book Value is -9.17%. Overall, Surgery Partners has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Surgery Partners' ROE % Adjusted to Book Value compare to AVAH and ASTH?
Surgery Partners' ROE % Adjusted to Book Value of -9.17% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Surgery Partners and its competitors. Surgery Partners's current ROE % Adjusted to Book Value is -9.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgery Partners stock overvalued right now?
Based on GuruFocus' analysis, Surgery Partners (SGRY) is currently considered Possible Value Trap. The stock's GF Value™ is $26.81, compared to a current price of $14.92 — trading 44.3% below its estimated fair value. The current ROE % Adjusted to Book Value is -9.17%. Surgery Partners' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Surgery Partners (SGRY), the current ROE % Adjusted to Book Value is -9.17% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Surgery Partners (SGRY) Overvalued in 2026?

Based on GuruFocus' analysis, Surgery Partners stock appears to be undervalued. The current stock price of $14.92 is trading 44.3% below its estimated GF Value™ of $26.81. GuruFocus considers Surgery Partners to be Possible Value Trap.

Key valuation signals for SGRY:

  • ROE % Adjusted to Book Value: -9.17%
  • GF Value™: $26.81 vs. price of $14.92 (44.3% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the SGRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Surgery Partners Business Description

Other Exchanges 1SP:Germany
Address 340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
66GF Score

Get the complete analysis for SGRY

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.92
Price
$26.81
GF Value